APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meperidine (Demerol)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Meperidine (Demerol) Industry Growth and Trends Forecast to 2032

26 December 2025102 pages

Choose your research edition.

Industry ResearchMeperidine (Demerol) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Meperidine (Demerol) Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Meperidine (Demerol) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meperidine (Demerol) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Meperidine (Demerol) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Meperidine (Demerol) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meperidine (Demerol) include Actavis Plc, Boehringer Ingelheim, Egalet, Endo Pharmaceuticals Inc, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, Sun Pharmaceutical Industries Ltd and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Meperidine (Demerol) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Meperidine (Demerol) market size, estimates, and forecasts are presented in terms of sales volume (mg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Meperidine (Demerol) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Meperidine (Demerol).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Meperidine (Demerol) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Meperidine (Demerol) Market by Company

Actavis Plc

Boehringer Ingelheim

Egalet

Endo Pharmaceuticals Inc

Janssen Pharmaceuticals

Mallinckrodt Pharmaceuticals

Purdue Pharma

Sun Pharmaceutical Industries Ltd

Pfizer Inc

Sanofi

Meperidine (Demerol) Segment by Type

Powder

Liquid

Meperidine (Demerol) Segment by Application

Anesthesia

Cough Suppressant

Diarrhea suppressant

Meperidine (Demerol) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meperidine (Demerol) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meperidine (Demerol) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meperidine (Demerol).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meperidine (Demerol) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Meperidine (Demerol) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Liquid Table 3. Global Meperidine (Demerol) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 5. Global Meperidine (Demerol) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Meperidine (Demerol) Sales Market Share in Value by Type (2021-2026) Table 8. Global Meperidine (Demerol) Price by Type (2021-2026) & (US$/g) Table 9. Global Meperidine (Demerol) Sales by Type (2027-2032) & (mg) Table 10. Global Meperidine (Demerol) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Meperidine (Demerol) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Meperidine (Demerol) Sales Market Share in Value by Type (2027-2032) Table 13. Global Meperidine (Demerol) Price by Type (2027-2032) & (US$/g) Table 14. North America Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 15. North America Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 17. Europe Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 19. Asia-Pacific Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 21. Latin America Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Meperidine (Demerol) Sales by Type (2021-2026) & (mg) Table 23. Middle East and Africa Meperidine (Demerol) Sales by Type (2021-2026) & (US$ Million) Table 24. Meperidine (Demerol) Industry Trends Table 25. Meperidine (Demerol) Industry Drivers Table 26. Meperidine (Demerol) Industry Opportunities and Challenges Table 27. Meperidine (Demerol) Industry Restraints Table 28. Global Meperidine (Demerol) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Meperidine (Demerol) Revenue Market Share by Company (2021-2026) Table 30. Global Meperidine (Demerol) Sales by Company (2021-2026) & (mg) Table 31. Global Meperidine (Demerol) Sales Share by Company (2021-2026) Table 32. Global Meperidine (Demerol) Market Price by Company (2021-2026) & (US$/g) Table 33. Global Meperidine (Demerol) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Meperidine (Demerol) Major Company Production Sites and Headquarters Table 35. Global Meperidine (Demerol) Company, Product Type & Application Table 36. Global Meperidine (Demerol) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Meperidine (Demerol) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Meperidine (Demerol) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Meperidine (Demerol) Sales by Region (2021-2026) & (mg) Table 41. Global Meperidine (Demerol) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Meperidine (Demerol) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Meperidine (Demerol) Sales Market Share in Value by Region (2021-2026) Table 44. Global Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Meperidine (Demerol) Sales by Region (2027-2032) & (mg) Table 46. Global Meperidine (Demerol) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Meperidine (Demerol) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Meperidine (Demerol) Sales Market Share in Value by Region (2027-2032) Table 49. Global Meperidine (Demerol) Sales (mg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Meperidine (Demerol) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 52. Global Meperidine (Demerol) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Meperidine (Demerol) Sales Market Share in Value by Application (2021-2026) Table 55. Global Meperidine (Demerol) Price by Application (2021-2026) & (US$/g) Table 56. Global Meperidine (Demerol) Sales by Application (2027-2032) & (mg) Table 57. Global Meperidine (Demerol) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Meperidine (Demerol) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Meperidine (Demerol) Sales Market Share in Value by Application (2027-2032) Table 60. Global Meperidine (Demerol) Price by Application (2027-2032) & (US$/g) Table 61. North America Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 62. North America Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 64. Europe Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 66. Asia-Pacific Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 68. Latin America Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Meperidine (Demerol) Sales by Application (2021-2026) & (mg) Table 70. Middle East and Africa Meperidine (Demerol) Sales by Application (2021-2026) & (US$ Million) Table 71. Actavis Plc Company Information Table 72. Actavis Plc Business Overview Table 73. Actavis Plc Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Actavis Plc Meperidine (Demerol) Product Portfolio Table 75. Actavis Plc Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Meperidine (Demerol) Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Egalet Company Information Table 82. Egalet Business Overview Table 83. Egalet Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Egalet Meperidine (Demerol) Product Portfolio Table 85. Egalet Recent Development Table 86. Endo Pharmaceuticals Inc Company Information Table 87. Endo Pharmaceuticals Inc Business Overview Table 88. Endo Pharmaceuticals Inc Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio Table 90. Endo Pharmaceuticals Inc Recent Development Table 91. Janssen Pharmaceuticals Company Information Table 92. Janssen Pharmaceuticals Business Overview Table 93. Janssen Pharmaceuticals Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 95. Janssen Pharmaceuticals Recent Development Table 96. Mallinckrodt Pharmaceuticals Company Information Table 97. Mallinckrodt Pharmaceuticals Business Overview Table 98. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio Table 100. Mallinckrodt Pharmaceuticals Recent Development Table 101. Purdue Pharma Company Information Table 102. Purdue Pharma Business Overview Table 103. Purdue Pharma Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Purdue Pharma Meperidine (Demerol) Product Portfolio Table 105. Purdue Pharma Recent Development Table 106. Sun Pharmaceutical Industries Ltd Company Information Table 107. Sun Pharmaceutical Industries Ltd Business Overview Table 108. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio Table 110. Sun Pharmaceutical Industries Ltd Recent Development Table 111. Pfizer Inc Company Information Table 112. Pfizer Inc Business Overview Table 113. Pfizer Inc Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. Pfizer Inc Meperidine (Demerol) Product Portfolio Table 115. Pfizer Inc Recent Development Table 116. Sanofi Company Information Table 117. Sanofi Business Overview Table 118. Sanofi Meperidine (Demerol) Sales (mg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 119. Sanofi Meperidine (Demerol) Product Portfolio Table 120. Sanofi Recent Development Table 121. North America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 122. North America Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 123. North America Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 124. North America Meperidine (Demerol) Sales Forecast by Country (2027-2032) & (mg) Table 125. North America Meperidine (Demerol) Sales Market Share Forecast by Country (2027-2032) Table 126. North America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Meperidine (Demerol) Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Meperidine (Demerol) Market Share by Country (2021-2026) Table 129. North America Meperidine (Demerol) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Meperidine (Demerol) Market Share Forecast by Country (2027-2032) Table 131. Europe Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 132. Europe Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 133. Europe Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 134. Europe Meperidine (Demerol) Sales Forecast by Country (2027-2032) & (mg) Table 135. Europe Meperidine (Demerol) Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Meperidine (Demerol) Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Meperidine (Demerol) Market Share by Country (2021-2026) Table 139. Europe Meperidine (Demerol) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Meperidine (Demerol) Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 143. Asia-Pacific Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Meperidine (Demerol) Sales Forecast by Country (2027-2032) & (mg) Table 145. Asia-Pacific Meperidine (Demerol) Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Meperidine (Demerol) Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Meperidine (Demerol) Market Share by Country (2021-2026) Table 149. Asia-Pacific Meperidine (Demerol) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Meperidine (Demerol) Market Share Forecast by Country (2027-2032) Table 151. Latin America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 152. Latin America Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 153. Latin America Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 154. Latin America Meperidine (Demerol) Sales Forecast by Country (2027-2032) & (mg) Table 155. Latin America Meperidine (Demerol) Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Meperidine (Demerol) Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Meperidine (Demerol) Market Share by Country (2021-2026) Table 159. Latin America Meperidine (Demerol) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Meperidine (Demerol) Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (mg): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Meperidine (Demerol) Sales by Country (2021-2026) & (mg) Table 163. Middle East and Africa Meperidine (Demerol) Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Meperidine (Demerol) Sales Forecast by Country (2027-2032) & (mg) Table 165. Middle East and Africa Meperidine (Demerol) Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Meperidine (Demerol) Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Meperidine (Demerol) Market Share by Country (2021-2026) Table 169. Middle East and Africa Meperidine (Demerol) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Meperidine (Demerol) Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Meperidine (Demerol) Distributors List Table 174. Meperidine (Demerol) Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Meperidine (Demerol) Image Figure 2. Global Meperidine (Demerol) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meperidine (Demerol) Market Size (2021-2032) & (US$ Million) Figure 4. Global Meperidine (Demerol) Sales (2021-2032) & (mg) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (mg) Figure 7. Liquid Image Figure 8. Global Liquid Sales YoY Growth (2021-2032) & (mg) Figure 9. Global Meperidine (Demerol) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Meperidine (Demerol) Market Share by Type 2025 VS 2032 Figure 11. North America Meperidine (Demerol) Sales Market Share in Volume by Type in 2025 Figure 12. North America Meperidine (Demerol) Sales Market Share in Value by Type in 2025 Figure 13. Europe Meperidine (Demerol) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Meperidine (Demerol) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Meperidine (Demerol) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Meperidine (Demerol) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Meperidine (Demerol) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Meperidine (Demerol) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Meperidine (Demerol) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Meperidine (Demerol) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Meperidine (Demerol) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Anesthesia Image Figure 24. Global Anesthesia Sales YoY Growth (2021-2032) & (mg) Figure 25. Cough Suppressant Image Figure 26. Global Cough Suppressant Sales YoY Growth (2021-2032) & (mg) Figure 27. Diarrhea suppressant Image Figure 28. Global Diarrhea suppressant Sales YoY Growth (2021-2032) & (mg) Figure 29. Global Meperidine (Demerol) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Meperidine (Demerol) Market Share by Application 2025 VS 2032 Figure 31. North America Meperidine (Demerol) Sales Market Share in Volume by Application in 2025 Figure 32. North America Meperidine (Demerol) Sales Market Share in Value by Application in 2025 Figure 33. Europe Meperidine (Demerol) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Meperidine (Demerol) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Meperidine (Demerol) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Meperidine (Demerol) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Meperidine (Demerol) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Meperidine (Demerol) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Meperidine (Demerol) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Meperidine (Demerol) Sales Market Share in Value by Application in 2025 Figure 41. North America Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 42. North America Meperidine (Demerol) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Meperidine (Demerol) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 46. Europe Meperidine (Demerol) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Meperidine (Demerol) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 50. Asia-Pacific Meperidine (Demerol) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Meperidine (Demerol) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 54. Latin America Meperidine (Demerol) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Meperidine (Demerol) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Meperidine (Demerol) Sales by Country: 2021 VS 2025 VS 2032 (mg) Figure 58. Middle East and Africa Meperidine (Demerol) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Meperidine (Demerol) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Meperidine (Demerol) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Meperidine (Demerol) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Anesthesia
  • Cough Suppressant
  • Diarrhea suppressant
Companies covered
  • Actavis Plc
  • Boehringer Ingelheim
  • Egalet
  • Endo Pharmaceuticals Inc
  • Janssen Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Purdue Pharma
  • Sun Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Meperidine (Demerol) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Meperidine (Demerol) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Meperidine (Demerol) Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Liquid
  8. 1.4 Global Meperidine (Demerol) Market Size by Type
  9. 1.4.1 Global Meperidine (Demerol) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Meperidine (Demerol) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Meperidine (Demerol) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Meperidine (Demerol) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Meperidine (Demerol) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Meperidine (Demerol) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Meperidine (Demerol) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Meperidine (Demerol) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Meperidine (Demerol) Industry Trends
  2. 2.2 Meperidine (Demerol) Industry Drivers
  3. 2.3 Meperidine (Demerol) Industry Opportunities and Challenges
  4. 2.4 Meperidine (Demerol) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Meperidine (Demerol) Revenue (2021-2026)
  2. 3.2 Global Top Players by Meperidine (Demerol) Sales (2021-2026)
  3. 3.3 Global Top Players by Meperidine (Demerol) Price (2021-2026)
  4. 3.4 Global Meperidine (Demerol) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meperidine (Demerol) Major Company Production Sites & Headquarters
  6. 3.6 Global Meperidine (Demerol) Company, Product Type & Application
  7. 3.7 Global Meperidine (Demerol) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meperidine (Demerol) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meperidine (Demerol) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meperidine (Demerol) Tier 1, Tier 2, and Tier 3
4 Meperidine (Demerol) Regional Status and Outlook
  1. 4.1 Global Meperidine (Demerol) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Meperidine (Demerol) Historic Market Size by Region
  3. 4.2.1 Global Meperidine (Demerol) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Meperidine (Demerol) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Meperidine (Demerol) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Meperidine (Demerol) Forecasted Market Size by Region
  7. 4.3.1 Global Meperidine (Demerol) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Meperidine (Demerol) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Meperidine (Demerol) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Meperidine (Demerol) by Application
  1. 5.1 Meperidine (Demerol) Market by Application
  2. 5.1.1 Anesthesia
  3. 5.1.2 Cough Suppressant
  4. 5.1.3 Diarrhea suppressant
  5. 5.2 Global Meperidine (Demerol) Market Size by Application
  6. 5.2.1 Global Meperidine (Demerol) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Meperidine (Demerol) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Meperidine (Demerol) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Meperidine (Demerol) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Meperidine (Demerol) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Meperidine (Demerol) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Meperidine (Demerol) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Meperidine (Demerol) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Actavis Plc
  2. 6.1.1 Actavis Plc Company Information
  3. 6.1.2 Actavis Plc Business Overview
  4. 6.1.3 Actavis Plc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Actavis Plc Meperidine (Demerol) Product Portfolio
  6. 6.1.5 Actavis Plc Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Meperidine (Demerol) Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Egalet
  14. 6.3.1 Egalet Company Information
  15. 6.3.2 Egalet Business Overview
  16. 6.3.3 Egalet Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Egalet Meperidine (Demerol) Product Portfolio
  18. 6.3.5 Egalet Recent Developments
  19. 6.4 Endo Pharmaceuticals Inc
  20. 6.4.1 Endo Pharmaceuticals Inc Company Information
  21. 6.4.2 Endo Pharmaceuticals Inc Business Overview
  22. 6.4.3 Endo Pharmaceuticals Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio
  24. 6.4.5 Endo Pharmaceuticals Inc Recent Developments
  25. 6.5 Janssen Pharmaceuticals
  26. 6.5.1 Janssen Pharmaceuticals Company Information
  27. 6.5.2 Janssen Pharmaceuticals Business Overview
  28. 6.5.3 Janssen Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio
  30. 6.5.5 Janssen Pharmaceuticals Recent Developments
  31. 6.6 Mallinckrodt Pharmaceuticals
  32. 6.6.1 Mallinckrodt Pharmaceuticals Company Information
  33. 6.6.2 Mallinckrodt Pharmaceuticals Business Overview
  34. 6.6.3 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio
  36. 6.6.5 Mallinckrodt Pharmaceuticals Recent Developments
  37. 6.7 Purdue Pharma
  38. 6.7.1 Purdue Pharma Company Information
  39. 6.7.2 Purdue Pharma Business Overview
  40. 6.7.3 Purdue Pharma Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Purdue Pharma Meperidine (Demerol) Product Portfolio
  42. 6.7.5 Purdue Pharma Recent Developments
  43. 6.8 Sun Pharmaceutical Industries Ltd
  44. 6.8.1 Sun Pharmaceutical Industries Ltd Company Information
  45. 6.8.2 Sun Pharmaceutical Industries Ltd Business Overview
  46. 6.8.3 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
  49. 6.9 Pfizer Inc
  50. 6.9.1 Pfizer Inc Company Information
  51. 6.9.2 Pfizer Inc Business Overview
  52. 6.9.3 Pfizer Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Inc Meperidine (Demerol) Product Portfolio
  54. 6.9.5 Pfizer Inc Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sanofi Meperidine (Demerol) Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Meperidine (Demerol) Sales by Country
  2. 7.1.1 North America Meperidine (Demerol) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Meperidine (Demerol) Sales by Country (2021-2026)
  4. 7.1.3 North America Meperidine (Demerol) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Meperidine (Demerol) Market Size by Country
  6. 7.2.1 North America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Meperidine (Demerol) Market Size by Country (2021-2026)
  8. 7.2.3 North America Meperidine (Demerol) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Meperidine (Demerol) Sales by Country
  2. 8.1.1 Europe Meperidine (Demerol) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Meperidine (Demerol) Sales by Country (2021-2026)
  4. 8.1.3 Europe Meperidine (Demerol) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Meperidine (Demerol) Market Size by Country
  6. 8.2.1 Europe Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Meperidine (Demerol) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Meperidine (Demerol) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Meperidine (Demerol) Sales by Country
  2. 9.1.1 Asia-Pacific Meperidine (Demerol) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Meperidine (Demerol) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Meperidine (Demerol) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Meperidine (Demerol) Market Size by Country
  6. 9.2.1 Asia-Pacific Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Meperidine (Demerol) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Meperidine (Demerol) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Meperidine (Demerol) Sales by Country
  2. 10.1.1 South America Meperidine (Demerol) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Meperidine (Demerol) Sales by Country (2021-2026)
  4. 10.1.3 South America Meperidine (Demerol) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Meperidine (Demerol) Market Size by Country
  6. 10.2.1 South America Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Meperidine (Demerol) Market Size by Country (2021-2026)
  8. 10.2.3 South America Meperidine (Demerol) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Meperidine (Demerol) Sales by Country
  2. 11.1.1 Middle East and Africa Meperidine (Demerol) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Meperidine (Demerol) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Meperidine (Demerol) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Meperidine (Demerol) Market Size by Country
  6. 11.2.1 Middle East and Africa Meperidine (Demerol) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Meperidine (Demerol) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Meperidine (Demerol) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Meperidine (Demerol) Value Chain Analysis
  2. 12.1.1 Meperidine (Demerol) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Meperidine (Demerol) Production Mode & Process
  7. 12.2 Meperidine (Demerol) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Meperidine (Demerol) Distributors
  10. 12.2.3 Meperidine (Demerol) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst